Ozempic and Zepbound branded options are listed at $1,299/month and $1,399/month respectively - substantially higher, which reflects the cost of FDA-approved branded medications versus compounded alternatives
Preventing Local Injection Site Reactions FDA labels for semaglutide and tirzepatide report injection-site reactions among possible adverse effects
Expected weight change: An additional 3 to 5% of body weight, bringing cumulative loss to approximately 9 to 17%
We are here to answer your questions, manage any side effects, and help you set realistic expectations for your weight loss journey
The ability to track trends over weeks and months reveals patterns that single point measurements miss
Its triple receptor agonism demonstrates potential benefits for enhanced weight loss and metabolic health, providing benefits over conventional single-receptor therapies